v3.25.2
Shareholder Report
12 Months Ended
May 31, 2025
USD ($)
Holdings
Shareholder Report [Line Items]  
Document Type N-CSR
Amendment Flag false
Registrant Name Columbia Funds Series Trust II
Entity Central Index Key 0001352280
Entity Investment Company Type N-1A
Document Period End Date May 31, 2025
Multi-Manager Value Strategies Fund - Institutional Class [Member]  
Shareholder Report [Line Items]  
Fund Name Multi-Manager Value Strategies Fund
Class Name Institutional Class
Trading Symbol CZMVX
Annual or Semi-Annual Statement [Text Block] This annual shareholder report contains important information about Multi-Manager Value Strategies Fund (the Fund) for the period of June 1, 2024 to May 31, 2025.
Shareholder Report Annual or Semi-Annual annual shareholder report
Additional Information [Text Block] You can find additional information about the Fund at
columbiathreadneedleus.com/resources/literature
. You can also request more information by contacting us at
1-800-345-6611.
Material Fund Change Notice [Text Block] This report describes changes to the Fund that occurred during the reporting period.
Additional Information Phone Number 1-800-345-6611
Additional Information Website columbiathreadneedleus.com/resources/literature
Expenses [Text Block]
What were the Fund costs for the reporting period?
(Based on a hypothetical $10,000 investment)
ClassCost of a $10,000 investmentCost paid as a percentage of a $10,000 investment
Institutional Class
$
71
0.69
%
Expenses Paid, Amount $ 71
Expense Ratio, Percent 0.69%
Factors Affecting Performance [Text Block]
Management's Discussion of Fund Performance
The performance of Institutional Class shares for the period presented is shown in the Average Annual Total Returns table.
Top Performance Contributors
Stock selection
| Selection in the health care and information technology sectors boosted the Fund’s relative results most during the annual period.
Allocations
| An underweight to the health care sector and an overweight to the information technology sector positively impacted relative performance.
Individual holdings
| Positions in Broadcom, Inc., a global semiconductor and infrastructure software solutions company, and Abbott Laboratories, a developer and manufacturer of health care products, and an underweight to Thermo Fisher Scientific, Inc., a health care life sciences tools and services provider, were among the top contributors to Fund relative performance.
Top Performance Detractors
Stock selection
 
I
 
Selection in the consumer staples, energy, industrials and materials sectors detracted from the Fund’s relative results during the annual period.
Allocations
| Overweights to the energy and consumer discretionary sectors, an underweight to the utilities sector and the Fund’s cash holdings detracted from relative performance.
Individual holdings
| Overweights to ConocoPhillips Co., an oil and gas exploration and production company, and Diamondback Energy, Inc., a developer of unconventional onshore oil and natural gas reserves, and not holding Phillip Morris International, a multi-national tobacco company with a growing percentage of smoke-free product sales, were among the top detractors.
Performance Past Does Not Indicate Future [Text] The Fund's past performance is not a good predictor of the Fund's future performance.
Line Graph [Table Text Block] Fund Performance - Growth of 10K
Average Annual Return [Table Text Block]
Average Annual Total Returns (%)1 year5 years10 years
Institutional Class
(a),(b)
6.4112.769.28
Russell 1000® Value Index8.9113.02 8.60
Russell 1000® Index13.7315.66 12.58
(a)
The returns shown for periods prior to January 3, 2017 (including Since Fund Inception returns, if shown) include the returns of Class A. Class A shares were offered prior to the Fund's Institutional Class shares but have since been merged into the Fund’s Institutional Class shares. These returns are adjusted to reflect any higher class-related operating expenses of the newer share classes, as applicable. Please visit
columbiathreadneedleus.com/investment-products/mutual-funds/appended-performance
for more information.
(b)
The Fund’s performance prior to May 27, 2025, reflects returns achieved by one or more different subadviser(s) that managed the Fund according to different principal investment strategies. If the Fund’s current subadvisers and strategies had been in place for the prior periods, results shown may have been different.
No Deduction of Taxes [Text Block] Performance does not reflect the deduction of taxes that a shareholder may pay on fund distributions or on the redemptions of fund shares.
Previous Investment Adviser [Text Block] The Fund’s performance prior to May 27, 2025, reflects returns achieved by one or more different subadviser(s) that managed the Fund according to different principal investment strategies. If the Fund’s current subadvisers and strategies had been in place for the prior periods, results shown may have been different.
Updated Performance Information Location [Text Block] Visit
columbiathreadneedleus.com/investment-products/mutual-funds
for more recent performance information.
Net Assets $ 4,982,358,659
Holdings Count | Holdings 352
Advisory Fees Paid, Amount $ 29,904,546
Investment Company, Portfolio Turnover 49.00%
Additional Fund Statistics [Text Block]
Fund net assets
$
4,982,358,659
Total number of portfolio holdings
352
Management services fees
(represents 0.59% of Fund average net assets)
$
29,904,546
Portfolio turnover for the reporting period
49%
Holdings [Text Block]
Graphical Representation of Fund
 
Holdings
The tables below show the investment makeup of the Fund represented as a percentage of Fund net assets. Derivatives are excluded from the tables unless otherwise noted. The Fund's portfolio composition is subject to change.
Top Holdings
JPMorgan Chase & Co.
2.6%
Abbott Laboratories2.0
%
American International Group, Inc.2.0
%
Exxon Mobil Corp.1.8
%
ConocoPhillips Co.1.7%
Union Pacific Corp.1.7
%
Amazon.com, Inc.1.6
%
Berkshire Hathaway, Inc., Class B1.6
%
Bank of America Corp.1.5%
Texas Instruments, Inc.1.5
%
Asset Categories
Graphical Representation - Allocation 1 Chart
Equity Sector Allocation
Graphical Representation - Allocation 2 Chart
Largest Holdings [Text Block]
Top Holdings
JPMorgan Chase & Co.
2.6%
Abbott Laboratories2.0
%
American International Group, Inc.2.0
%
Exxon Mobil Corp.1.8
%
ConocoPhillips Co.1.7%
Union Pacific Corp.1.7
%
Amazon.com, Inc.1.6
%
Berkshire Hathaway, Inc., Class B1.6
%
Bank of America Corp.1.5%
Texas Instruments, Inc.1.5
%
Material Fund Change [Text Block]
Certain Fund Changes
This is a summary of certain changes to the Fund during the reporting period. For more complete information, you may review the Fund’s prospectus, which is available at
columbiathreadneedleus.com/resources/literature
or upon request at
1-800-345-6611
.
Effective May 27, 2025 (the Effective Date), Dimensional Fund Advisors, LP (DFA) no longer serves as a subadviser to the Fund and American Century Investment Management, Inc. (American Century) assumed day-to-day management of a portion of the Fund’s portfolio. Accordingly, as of the Effective Date, the Fund’s principal investment strategies are revised to replace DFA's investment strategy and process with that of American Century.
Material Fund Change Strategies [Text Block] Accordingly, as of the Effective Date, the Fund’s principal investment strategies are revised to replace DFA's investment strategy and process with that of American Century.
Material Fund Change Adviser [Text Block] Effective May 27, 2025 (the Effective Date), Dimensional Fund Advisors, LP (DFA) no longer serves as a subadviser to the Fund and American Century Investment Management, Inc. (American Century) assumed day-to-day management of a portion of the Fund’s portfolio.
Summary of Change Legend [Text Block] This is a summary of certain changes to the Fund during the reporting period. For more complete information, you may review the Fund’s prospectus, which is available at
columbiathreadneedleus.com/resources/literature
or upon request at
1-800-345-6611
.
Updated Prospectus Phone Number 1-800-345-6611
Updated Prospectus Web Address columbiathreadneedleus.com/resources/literature